Skip to content
★ Sign in to follow
ML

Matthew Link

Insider activity · 24 months0 buys2 salesCumulative net flow
Total declarations
101
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (20 ops.)
€3.6M

Latest filing published 07 Jul 2025 for Sight Sciences, Inc., €17k.

Filing timeline

BuySale
Matthew Link

Insider track record

Disclosed buys
0
Disclosed sells
20
Signal history

Matthew Link: trading record in brief

This profile gathers the share dealings of Matthew Link across 2 companies, led by Nuvasive Inc and Sight Sciences, Inc. Over a trading history stretching from 1 January 2013 to 2 July 2025, the count stands at 101 filings.

The open-market record consists of 20 sales worth €3.6M, with no purchase. Outside the open market, there are 54 share grants and 21 option exercises. Since January 2025: no purchases and 2 sales on the market.

The latest filing, published on 7 July 2025, reports an open-market sale of €17k in Sight Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Matthew Link

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations101 total
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    20,035 USD30SEC
    4,889 shares@ US$4.0986.3% of flowCommon StockSEC:0000950170-25-094421:0
  • ◆
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    20,012 USD12SEC
    6,631 shares@ US$3.0186.6% of flowCommon StockSEC:0000950170-25-075986:0
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    11,642 USD29SEC
    5,042 shares@ US$2.3093.9% of flowCommon StockSEC:0000950170-25-050867:0
  • ◆
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    0SEC
    172,043 shares0Common StockSEC:0000950170-25-039076:0
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    122,472 USD31SEC
    21,831 shares@ US$5.6122.8% of flowCommon StockSEC:0000950170-24-116075:1
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    122,451 USD33SEC
    20,487 shares@ US$5.97741.7% of flowCommon StockSEC:0000950170-24-116075:0
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    122,465 USD31SEC
    20,970 shares@ US$5.8422.7% of flowCommon StockSEC:0000950170-24-115724:1
  • ▼
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    122,434 USD33SEC
    20,734 shares@ US$5.90541.5% of flowCommon StockSEC:0000950170-24-115724:0
  • ◆
    Chief Commercial OfficerExecutivesSight Sciences, Inc.
    0SEC
    747,572 shares0Common StockSEC:0000950170-23-064604:0
  • ▼
    PresidentExecutivesNuvasive Inc
    201,000 USD23SEC
    3,000 shares@ US$67.009.3% of flowCommon StockSEC:0001209191-20-035649:0
  • ◆
    PresidentExecutivesNuvasive Inc
    182,228 USD23SEC
    2,769 shares@ US$65.818.7% of flowCommon StockSEC:0001209191-20-015516:1
  • ◇
    PresidentExecutivesNuvasive Inc
    0SEC
    7,929 shares0Common StockSEC:0001209191-20-015516:0
  • ▼
    PresidentExecutivesNuvasive Inc
    239,400 USD23SEC
    3,000 shares@ US$79.806.4% of flowCommon StockSEC:0001209191-20-004138:0
  • ●
    PresidentExecutivesNuvasive Inc
    0SEC
    695 shares0Common StockSEC:0001209191-19-062039:0
  • ▼
    PresidentExecutivesNuvasive Inc
    270,830 USD23SEC
    3,500 shares@ US$77.387.3% of flowCommon StockSEC:0001209191-19-062039:1
  • ◇
    PresidentExecutivesNuvasive Inc
    553,000 USD23SEC
    12,500 shares@ US$44.2415.0% of flowCommon StockSEC:0001209191-19-062039:2
  • ◇
    PresidentExecutivesNuvasive Inc
    6,921 USD22SEC
    260 shares@ US$26.620.2% of flowCommon StockSEC:0001209191-19-062039:3
  • ◆
    PresidentExecutivesNuvasive Inc
    673,814 USD24SEC
    8,672 shares@ US$77.7018.2% of flowCommon StockSEC:0001209191-19-062039:4
  • ▼
    PresidentExecutivesNuvasive Inc
    626,200 USD24SEC
    10,100 shares@ US$62.0016.8% of flowCommon StockSEC:0001209191-19-027822:0
  • ◇
    PresidentExecutivesNuvasive Inc
    0SEC
    19,157 shares0Common StockSEC:0001209191-19-016829:0
  • ◆
    PresidentExecutivesNuvasive Inc
    424,974 USD23SEC
    7,267 shares@ US$58.4811.1% of flowCommon StockSEC:0001209191-19-016829:1
  • ◇
    PresidentExecutivesNuvasive Inc
    0SEC
    2,660 shares0Common StockSEC:0001209191-19-006918:0
  • ◆
    PresidentExecutivesNuvasive Inc
    50,702 USD22SEC
    1,032 shares@ US$49.131.3% of flowCommon StockSEC:0001209191-19-006918:1
  • ◇
    President, Strat/Tech/Corp DevExecutivesNuvasive Inc
    17,410 USD22SEC
    500 shares@ US$34.820.5% of flowCommon StockSEC:0001209191-18-063551:0
  • ◆
    President, Strat/Tech/Corp DevExecutivesNuvasive Inc
    17,380 USD22SEC
    327 shares@ US$53.150.5% of flowCommon StockSEC:0001209191-18-063551:1

25 of 101 declarations